“…7 For SARS-CoV-2, few studies have been recently published fully addressing the label-free optical biosensing of viral particles, [10][11][12] viral RNA, 13 or viral antigens. 14 Besides, photonic biosensors have been developed for serological assays through the detection and quantification of COVID-19 antibodies, although only a few have been clinically validated. 15,16 Nonetheless, the sensitivity levels achieved so far for the direct detection of SARS-CoV-2 infection have not reached yet the clinical standards set by PCR-based assays, or they involve costly and sophisticated instrumentation and bioreagents making them unsuitable for eventual implementation for POC mass testing.…”